Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking strategy to diabetes management. These innovative medications work by mimicking the physiological actions of GLP-1, a hormone released by the https://socialislife.com/story6308126/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes